Clinical studies recruiting near Graz

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
NA · Medical University of Graz · Medical University Innsbruck · NCT05931783 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · St Elisabeth sister's Hospital · University Hospital, Geneva · NCT06207383 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 0400003 · Sanofi · NCT06867094 Austrian PBC Registry
Phase N/A · Medizinische Universität Graz · Medical University of Vienna · NCT07598669 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Medical University Of Graz · Princess Maxima Center for Pediatric Oncology · NCT05327894 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Medizinische Universität Graz · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · LKH - Medizinische Universitaet Graz · Miltenyi Biomedicine GmbH · NCT04844866 Diabetes Registry Graz for Biomarker Research
Phase N/A · Medical University of Graz · Medical University of Graz · NCT05324488 The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention
NA · Medical University of Graz · Medical University of Graz · NCT07588282 Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · University Hospital Graz · Vastra Gotaland Region · NCT06419946 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Medizinische Universitaet Graz · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Medizinische Universitat Graz ( Site 0303) · Merck Sharp & Dohme LLC · NCT07216703 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Uniklinik Graz, Endokrinologie und Diabetes · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Medizinische Universität Graz · Eli Lilly and Company · NCT06890598 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · LKH-Univ. Klinikum Graz · Janssen Research & Development, LLC · NCT07499232 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Medical University Graz · Regeneron Pharmaceuticals · NCT06091865 SELUTION4BTK Trial
NA · LKH-Universitätsklinikum Graz · M.A. Med Alliance S.A. · NCT05055297 Anxiety, Stress and Pain & Myocardial Infarction
Phase N/A · Medical University of Graz · Medical University of Graz · NCT04130269 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Medizinische Universität Graz · Eli Lilly and Company · NCT06937086 Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematologi
Phase N/A · Medizinische Universität Graz · Medical University Innsbruck · NCT06821880 NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-
NA · Unfallkrankenhaus Graz · AUVA · NCT04474106 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Universitätsklinikum Graz · Goethe University · NCT02872987 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Medizinische Universitaet Graz · Amgen · NCT07005128 Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · Universitätsklinik für Kinder- und Jugendchirurgie · University of Leipzig · NCT03469609 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Medizinische Universitaet Graz - Klinik fuer Innere Medizin · SAb Biotherapeutics, Inc. · NCT07187531 Periinterventional Coagulation Management of Patients Undergoing a TIPS
NA · Department of Internal Medicine, Medical University of Graz · Medical University of Graz · NCT04421924 The Effect of Griffonia Simplicifolia on Pain Intensity, Central and Peripheral Sensitization, Painmodulation in Healthy
NA · Medical University of Graz · Medical University of Graz · NCT06893822 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · LKH-Univ. Klinikum Graz · Bristol-Myers Squibb · NCT05489705

Look up another city

Look up another condition